Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...

Congenital heart disease (CHD) is the most common type of birth defect with an incidence of approximately 10 per 1,000, ranging from 2.3 to 13.1 in 1,000 live births based on the geographic region, ...

Genetic tests for Alzheimer’s can detect specific genes linked to the disease. In most cases, they can’t definitively confirm or predict a diagnosis, but they can provide insight into your relative ...

Congenital heart disease (CHD) encompasses diseases affecting heart morphology and function due to abnormalities in the development of heart, valve, or vascular tissue structures. CHD is mainly ...

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Germline genetic testing can play an essential role in identifying cancer risk, guiding treatment decisions, and informing screening and/or preventive strategies for both patients and patient family ...